Chronic Kidney Disease Clinical Trial
Official title:
The Quantitative Ultrasound Assessment of Lean and Intramuscular Adipose Tissue in Veterans With Chronic Kidney Disease
Currently there is no standard way to detect age-related skeletal muscle loss in patients with chronic kidney disease. Investigators are working on finding rapid and inexpensive ways to measure muscle size and fat within the muscle.
The accelerated muscle wasting associated with chronic kidney disease (CKD) is a source of
morbidity and an increased incidence of bone fracture secondary to falls. However, sarcopenia
secondary to CKD is not routinely screened or assessed in this patient population. This
protocol, "Quantitative Ultrasound Assessment of Lean and Intramuscular Adipose Tissue in
Veterans Project" (i.e., QUALITY VETS) is a VA Center for Innovation (VACI) funded pilot
study with the purpose of using a clinically viable sarcopenia screening approach for
Veterans with CKD who are currently receiving care at the Renal Service.
The investigative team will screen and assess diminished muscle mass, quality, and
performance in Veterans with CKD (Stage 3 and 4), and also examine the relationship between
the muscle characteristics and estimated fall risk within the sample. Key outcome measures
will be obtained within the domains of muscle performance (peak grip strength), functional
status (Short Physical Performance Battery), estimates of tissue/body composition (diagnostic
ultrasound and DXA), and fall risk (Timed Up-and-Go test). Secondary measures will include
questionnaires regarding of fall avoidance, physical activity, depression, and quality of
life (QoL).
The general analysis approach will be to characterize the proportion of participants with:
sarcopenia based on the European Working Group on Sarcopenia in Older People (EWGSOP)
algorithm, low muscle quality based on preliminary echogenicity cut off values and criterion
strength values, and an elevated risk of falling based on the Timed Up-and-Go age-dependent
cut off values. Investigators will determine the magnitude of association between the
skeletal muscle outcomes and fall risk within the participant sample. Hazard ratios will be
used to estimate the impact of the sarcopenia classification and echogenicity values on the
positive classification of fall risk.
The optimal treatment of Veterans with CKD who have an elevated risk of falls may be enhanced
by the timely identification of accelerated muscle changes. The QUALITY-VETS Project will
help to determine appropriate screening and assessment strategies that could be implemented
in subsequent longitudinal studies involving exercise interventions and fall prevention
training.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05491642 -
A Study in Male and Female Participants (After Menopause) With Mild to Moderate High Blood Pressure to Learn How Safe the Study Treatment BAY3283142 is, How it Affects the Body and How it Moves Into, Through and Out of the Body After Taking Single and Multiple Doses
|
Phase 1 | |
| Recruiting |
NCT06363097 -
Urinary Uromodulin, Dietary Sodium Intake and Ambulatory Blood Pressure in Patients With Chronic Kidney Disease
|
||
| Terminated |
NCT04043026 -
The Effects of Renal Function and Atrial Fibrillation on Lipoproteins and Clot Structure/Function
|
||
| Completed |
NCT05318014 -
Low-protein Formula Supplements in Chronic Kidney Disease
|
N/A | |
| Active, not recruiting |
NCT06071065 -
Clinical Pharmacist Intervention on Medication Adherence and Clinical Outcomes in Chronic Kidney Disease Patients
|
N/A | |
| Completed |
NCT02878317 -
Skin Autofluorescence as a Risk Marker in People Receiving Dialysis.
|
||
| Not yet recruiting |
NCT06039254 -
Safety and Pharmacokinetics of HRS-1780 in Healthy Subjects and Subjects With Impaired Renal Function
|
Phase 1 | |
| Completed |
NCT02756520 -
Observational Study on CKD Treatment With a Ketosteril Supplemented Protein-restricted Diet (Keto-024-CNI)
|
||
| Completed |
NCT02896309 -
The Effect of Correction of Metabolic Acidosis in CKD on Intrarenal RAS Activity
|
N/A | |
| Completed |
NCT02888171 -
Impact of Ferric Citrate vs Ferrous Sulfate on Iron Parameters and Hemoglobin in Individuals With CKD and Iron Deficiency
|
N/A | |
| Completed |
NCT02875886 -
DD-study: Diet or Diuretics for Salt-sensitivity in Chronic Kidney Disease
|
Phase 4 | |
| Withdrawn |
NCT02885545 -
The Strategy to Prevent Hemorrhage Associated With Anticoagulation in Renal Disease Management (STOP HARM) Trial
|
Phase 4 | |
| Completed |
NCT02836574 -
A Study of Renal Autologous Cell Therapy (REACT) in Type 2 Diabetics With Chronic Kidney Disease
|
Phase 2 | |
| Active, not recruiting |
NCT02483039 -
Nephrologist Follow-up Versus Usual Care After an Acute Kidney Injury Hospitalization
|
N/A | |
| Completed |
NCT02369549 -
Micro-Particle Curcumin for the Treatment of Chronic Kidney Disease
|
Phase 3 | |
| Completed |
NCT02992548 -
Effect of Pravastatin on Erythrocyte Membrane Fatty Acid Contents in Patients With Chronic Kidney Disease
|
Phase 4 | |
| Terminated |
NCT02543177 -
Optimised Procedure in Patients With NSTEMI and CKD
|
N/A | |
| Recruiting |
NCT02205944 -
Impact of Presurgical Exercise on Hemodialysis Fistula Outcomes
|
N/A | |
| Active, not recruiting |
NCT02231138 -
Efficacy and Safety of Abelmoschus Manihot for Chronic Kidney Disease
|
Phase 4 | |
| Completed |
NCT02492672 -
Registry to Evaluate Maintenance Treatment With Venofer in Pediatric Patients With Chronic Kidney Disease
|